Skip to main content
Signal8

ClearPoint Neuro, Inc. (CLPT)

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc.

NASDAQ:CLPTHealthcare
-0.19%$10.67
AH$10.86+1.78%vs close
Mkt Cap$342.02M
Float28.31M
O/S32.05M
Vol
$ Vol
RVOL
Inst Own43.2%
SI16.4%
Earnings
Dilution
Trials3 trials as collaborator·1 active2 completed(no lead-sponsored trials found)

Trials need funding. See this company's dilution risk and cash position.

Clinical Trials
Status
  • Not applicable
    Completed

    Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures

    Collaborator · Lead: Johns Hopkins University

    Simvastatin (20mg versus 80mg/day)

    Heart Diseases

    Enrollment
    72
    Start
    Aug 2000
    Primary Completion
    -
    Completion
    Apr 2004
    NCT00125060
  • Observational
    Completed

    Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes

    Collaborator · Lead: University of California, San Francisco

    interventional MRI for implantation of DBS electrodes, DBS electrodes

    Parkinson's Disease, Dystonia

    Enrollment
    8
    Start
    Jul 2003
    Primary Completion
    Mar 2019
    Completion
    Mar 2019
    NCT00792532
  • Not applicable
    Recruiting

    Deployment of Irrigating Intraventricular Catheter System for Intraventricular Hemorrhage

    Collaborator · Lead: Icahn School of Medicine at Mount Sinai

    IRRAflow® Active Fluid Exchange System, Traditional extraventricular drain

    Intraventricular Hemorrhage (IVH)

    Enrollment
    17
    Start
    Jun 2022
    Primary Completion
    Dec 2026est.
    Completion
    Dec 2026est.
    NCT05970549